Light Sciences Oncology

Light Sciences Oncology of Snoqualmie, Wash., has purchased the assets of its parent company, Light Sciences LLC, through the issuance of common stock. Acquisitions include all patents and other assets of the latter company and its five subsidiaries. With the purchase, Light Sciences Oncology intends to improve its light infusion therapy technology, which uses a variation on photodynamic therapy with red LEDs to treat cancer in solid tumors.





LATEST NEWS

• The Winds of Change Are Blowing Through the Photonics Industry
  May 3, 2024
• PsiQuantum to Build Utility-Scale Quantum Computer in Australia
  May 3, 2024
• Tyndall, MIT Partner on Sustainable Chip Production Processes: Week in Brief: 5/3/24
  May 3, 2024
• Headwall Taps Jim Gareau to Lead Optical Components and Assemblies Unit
  May 2, 2024
• Cognex Names Former Siemens VP Dennis Fehr CFO
  May 2, 2024
• 3D Holography Integrated Glasses Could Unlock Mixed Reality
  May 2, 2024
• Generative AI Achieves Superresolution with Minimal Tuning
  May 2, 2024
• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024